Dorsey Wright & Associates Ardelyx, Inc. Transaction History
Dorsey Wright & Associates
- $378 Million
- Q1 2024
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
198Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$130 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$101 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$78.9 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$40.1 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $911M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...